Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

INFLIFE:SV

31.44 EUR 0.36 1.14%

As of 09:48:00 ET on 04/16/2015.

Snapshot for Infond Life (INFLIFE)

Year To Date: +22.82% 3-Month: +14.78% 3-Year: +30.95% 52-Week Range: 19.87 - 31.91
1-Month: +1.27% 1-Year: +58.07% 5-Year: +19.67% Beta vs SBITOP: 0.40

Mutual Fund Chart for INFLIFE

No chart data available.
  • INFLIFE:SV 31.44
  • 1M
  • 1Y
Interactive INFLIFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for INFLIFE

Infond Life is an open-end investment fund incorporated in Slovenia. The Fund's objective is to invest primarily in companies from healthcare sector. The Fund's objective is capital appreciation.

Inception Date: 06-04-2007 Telephone: 386-2-229-2080
Managers: BARBARA GACNIK
Web Site: www.infond.si

Fundamentals for INFLIFE

NAV (on 2015-04-16) 31.44
Assets (M) (on 2015-04-16) 38.61
Fund Leveraged N
Minimum Investment 12.00
Minimum Subsequent Investment -

Dividends for INFLIFE

No dividends reported

Fees & Expenses for INFLIFE

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.33

Top Fund Holdings for INFLIFE

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 18,740 1,726,580 4.730%
Pfizer Inc 51,666 1,675,476 4.590%
Roche Holding AG 5,854 1,503,913 4.120%
Johnson & Johnson 14,559 1,365,203 3.740%
Merck & Co Inc 22,210 1,189,990 3.260%
Gilead Sciences Inc 12,850 1,175,388 3.220%
Actavis plc 3,803 1,054,929 2.890%
Bayer AG 7,412 1,033,028 2.830%
UnitedHealth Group Inc 9,104 1,003,826 2.750%
Amgen Inc 6,712 1,000,175 2.740%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil